CTOs on the Move

Francisco Partners

www.franciscopartners.com

 
Francisco Partners is a leading global investment firm that specializes in partnering with technology and technology-enabled businesses. Since its launch over 20 years ago, Francisco Partners has invested in over 400 technology companies, making it one of the most active and longstanding investors in the technology industry. With approximately $45 billion in capital raised to date, the firm invests in opportunities where its deep sectoral knowledge and operational expertise can help companies realize their full potential.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Jason Warner
Managing Director and Head of Data Science Profile

Funding

Francisco Partners raised $200M on 07/03/2017

Similar Companies

GoAhead Ventures

At GoAhead Ventures our mission is to work with young entrepreneurs at the earliest stages of their company. We are active investors who work alongside our companies and aim to deliver tangible value. We enjoy working with students and recent graduates to help them achieve their vision. We believe in the transformative ability that young entrepreneurs possess when building a company. We have a track record of helping entrepreneurs found their startups from scratch, and we love to get involved in every step of the process. Two thirds of our firm is made up of very recent Stanford grads, and the other third is very young at heart!

Terra Capital Partners

Terra Capital Partners is a New York, NY-based company in the Financial Services sector.

Blue Harbour

Blue Harbour is a Greenwich, CT-based company in the Financial Services sector.

Perimeter Financial

Perimeter Financial is a Toronto, ON-based company in the Financial Services sector.

Omega Fund

Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world`s most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories. Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation. Omega Funds has raised more than $1 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA.